AGC Launches €240M Offer For Italian Biotech Molmed
Japanese glass manufacturing giant AGC Inc. has offered to buy Gattai Minoli-advised medical technology company Molmed for up to €240 million ($267 million), the companies said Tuesday, in a deal meant...To view the full article, register now.
Already a subscriber? Click here to view full article